510(k) Report

510(k) · Cleared

Cleared

Nxstage System One with Therapeutic Plasma Exchange Cartridge

K093069510(k) TraditionalCleared Oct 23, 2010388-day reviewClass II21 CFR 876.5860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nxstage Medical, Inc. · KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System

Cleared on Oct 23, 2010 after a 388-day review. The FDA summary names no predicate by number. 11 later devices descend from it.

Decided
Oct 23, 2010
Review
388 days
Class
Class II
Product code
KDI
Recalls
None
Predicates
0

11 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2013: 1 descendant cleared2015: 2 descendants cleared2014: 3 descendants cleared2026: 1 descendant cleared2024: 1 descendant cleared2017: 2 descendants cleared2023: 1 descendant cleared2010201520202025
  1. This deviceK093069 Nxstage System One with Therapeutic Plasma Exchange CartridgeNxstage Medical, Inc. · 2010
  2. Descendant · cites it directly · 9 of its ownK122051 Nxstage System OneNxstage Medical, Inc. · 2013 · Recalled
  3. Descendant · 2 generations on · 6 of its ownK140526 Nxstage System OneNxstage Medical, Inc. · 2014 · Recalled
  4. Descendant · 3 generations on · 5 of its ownK141752 Nxstage System OneNxstage Medical, Inc. · 2014
  5. Descendant · 4 generations on · 1 of its ownK170469 NxStage System One PlusNxstage Medical, Inc. · 2017
  6. Descendant · 4 generations on · 1 of its ownK150472 NxStage System OneNxstage Medical, Inc. · 2015

Showing 5 of 11 descendants. See all descendants

Descendants cleared per year

2013: 12014: 32015: 22017: 22023: 12024: 12026: 1
2013high 3 (2014) · low 0 (2016)2026

Most influential descendants

Showing 5 of 11 · See all
  • K122051Nxstage System OneNxstage Medical, Inc. · 2013 · cites it directly9descendants
  • K140526Nxstage System OneNxstage Medical, Inc. · 2014 · 2 generations on6descendants
  • K141752Nxstage System OneNxstage Medical, Inc. · 2014 · 3 generations on5descendants
  • K170469NxStage System One PlusNxstage Medical, Inc. · 2017 · 4 generations on1descendant
  • K150472NxStage System OneNxstage Medical, Inc. · 2015 · 4 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K093069Nxstage System One with Therapeutic Plasma Exchange CartridgeNxstage Medical, Inc.2010—
+1K122051Nxstage System OneNxstage Medical, Inc.20131
+2K140526Nxstage System OneNxstage Medical, Inc.20142
+3K141752Nxstage System OneNxstage Medical, Inc.2014—
+4K170469NxStage System One PlusNxstage Medical, Inc.2017—
+4K150472NxStage System OneNxstage Medical, Inc.2015—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201310
201430
201520
201720
202310
202410
202610
FIG. 1 — Lineage of K093069, 2010–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KDI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KDI device

  1. #1 K243874 FX CorAL 60 (F00012969); FX CorAL 80…score 18.2 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (11)

See all 11

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K122051Nxstage System OneNxstage Medical, Inc.20139
K143313NxStage Therapeutic Plasma Exchange (TPE) CartridgeNxstage Medical, Inc.20150

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K122051 (Nxstage Medical, Inc., 2013) has gone furthest, with 9 descendants of its own.

How does its category compare?

All KDI devices

KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · KDI

9in 2025

2007: 112008: 62009: 42010: 92011: 52012: 62013: 112014: 82015: 52016: 52017: 82018: 22019: 42020: 92021: 22022: 72023: 72024: 72025: 92026 (partial year): 6
2007high 11 (2007) · low 2 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KDI

199in 2025

2007: 91 days median2008: 148 days median2009: 236 days median2010: 186 days median2011: 85 days median2012: 153 days median2013: 247 days median2014: 164 days median2015: 69 days median2016: 230 days median2017: 188 days median2019: 263 days median2020: 266 days median2022: 259 days median2023: 157 days median2024: 235 days median2025: 199 days median2026 (partial year): 154 days median
2007high 266 (2020) · low 69 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KDI

2in 2025

2007: 42009: 32010: 12011: 42012: 12013: 22014: 32015: 52016: 42017: 12018: 12019: 62021: 22022: 172023: 8, 8 Class I2024: 4, 2 Class I2025: 22026 (partial year): 2
2007high 17 (2022) · low 0 (2008)2026

Class I (10 since 2007) Class II/III not classified

Adverse event reports per year · KDI

2,786in 2025

2007: 9162008: 1,0422009: 5222010: 8232011: 2,2702012: 1,7652013: 2,3602014: 6,1542015: 4,1822016: 7662017: 9632018: 1,7162019: 1,5872020: 1,6332021: 1,9442022: 2,1802023: 2,6922024: 2,4412025: 2,786
2007high 6,154 (2014) · low 522 (2009)2025

MAUDE reports naming product code KDI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200711914916
2008614801,042
200942363522
201091861823
201158542,270
2012615311,765
20131124722,360
2014816436,154
201556954,182
201652304766
201781881963
20182—11,716
2019426361,587
2020926601,633
20212—21,944
20227259172,180
202371578 (8)2,692
202472354 (2)2,441
2025919922,786
202661542—

What is it indicated for?

The NxStage System One is indicated for the treatment of acute and chronic renal failure or fluid overload using hemofiltration, hemodialysis, and/or ultrafiltration, in an acute or chronic care facility. The System is indicated for hemodialysis with or without ultrafiltration in the home.

The NxStage System One is also indicated for Therapeutic Plasma Exchange in a clinical environment.

All treatments must be administered under a physician’s prescription, and must be observed by a trained and qualified person, considered to be competent in the use of this device by the prescribing physician.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K093069: Nxstage System One with Therapeutic Plasma Exchange Cartridge.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K093069

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026